Abstract
A new reverse phase liquid chromatographic method for the investigation of emtricitabine in rat plasma was developed after oral administration to Wistar rats. The desired chromatographic separation was achieved on Phenomenex C18 column (250mm × 4.6mm I.D., 5µm) column, under isocratic conditions using UV detection at 280nm. The optimized mobile phase consisted of a mixture of 10mM potassium dihydrogen phosphate buffer- (adjusted to pH 6.8) methanol-2% acetic acid in a ratio of (73:25:2, v/v/v) at a flow rate of 1mLmin−1. The system was found to produce sharp and well-resolved peaks for emtricitabine with retention time of 5.78min. The linear regression analysis for the calibration curves showed a good linear correlation over the concentration range 0.0503.0µgmL−1, with determination coefficients, , exceeding 0.9970. The limits of detection (LOD) and quantitation (LOQ) were found to be 0.016µgmL−1 and 0.049µgmL−1, respectively. The method was successfully applied for the pharmacokinetic in rats. Emtricitabine concentration in plasma reached ( ) was 1.357µgmL−1 about 2h after oral administration of 15mg/kg/rat. The AUC0-24 was 12.175µgmL−1* h and the apparent elimination half-life ( ) was 8.153h. This method was found to be suitable for examining emtricitabine concentration in rats, after oral administration of emtricitabine in a single dose.
Funding Information
  • Indian Council of Medical Research (45/38/2011/Nan-BMS)

This publication has 11 references indexed in Scilit: